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1. IN'FRODUCTION 
Tile enzyme diacylglycerol kinasc (DG kinase) is 
thought ~o be mainly involved in the regeneration of 
13hosphatidylinositol (PI) from diacylglycerol (DG) in 
the PI-cyclc during cell signal transduction [2,3]. In this 
process, DG kinase can be viewed as a modulator that 
competes with PKC for tile second messenger DG [4]. 
Transformation of 3T3 cells by the ras  onco~ene results 
in constitutively increased levels of DG and membrane- 
bound PKC activity, accompanied by a decrease in 
membrane-bound DG kinase activity, suggesting a 
possible role for DG kinase in ras  cell transformation 
[5,6]. The demonstration that the product of DG kinase 
activity, phosphatidic acid (PA), is itself mitogenic pro- 
vides a second way in which the enzyme may be involv- 
ed in signal transduction [7,8]. 
Understanding the possible role of DG kinase in 
transmembrane signalling requires a thorough study of 
its molecular and enzymatic properties. At present, 
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The DNA sequence will be submitted to EMBL data library 
most studies have been performed with cell lysates and 
partially purified DG kinase preparations. Recent 
reports indicate the presence of various types of DG 
kinases, that differ in cellular localization, substratc 
specificity and molecular weight [9-13]. 
Here we report the purification and characterization 
of a 86 kDa DG kinase from lauman normal white blood 
cells (WBC). Based on partial amino acid sequences of 
the purified DG kinase, primers were designed that 
have allowed the cloning of a human DG kinase eDNA 
by use of the polylnerase chain reaction (PCR), 
resulting in the complete amino acid sequence of the en- 
zyme. While we completed the eDNA ~ sequence of 
human DG kinase, the primary structure of porcine DG 
kinase was reported [1]. The DG kinase sequence 
reported here is the human equivalent of the porcine en- 
zyme. 
2. MATERIALS AND METHODS 
2.1. Materials 
All materials were from either Sit, ran, Merck or BDH unless tated 
otherwise. 2.Monooleoyl-rac.glycerol and l-oleoyl-lyso-3.sn- 
phosphatidic acid were from Serdary (Ontario, Canada); l-O- 
hexadecyl.2.0.methyl.rac-glycerol and 1,2-O-dioctadecyl-sn-glycercl 
from Bachem (Bubenheim, Switzerland); adenosine 5'-IT-riP]- 
It;phosphate (3000 Ci/mmol) from Amersham; acrylamide from Ser- 
va (Heidelbers, FRG); dithiothreitol and adenosine 5'.triphosphate 
from Boehringer; R59022 from Janssen (Belgium). l.Palmitoyl-2- 
oleo>q- and l°O.hexadecyl.2.oleoyl-sn-glycerol wereprepared in our 
laboratory from their respective PC homologues by reaction with 
phosphollpase C [14] and purified by HPLC [15], 
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Wi l t :  ~¢fe i~,~lated ft'ola 2J ,50 l i lcf~ o f  I~lood. ¢l~,~'Iitl'Of,%lc~ l~fl" 
ly~¢il i l l ld WI l t '  ~¢1'¢ ~¢dhli¢l l led l'~f 1,4 l l l i i l  ill 21~illl .: t., I 'hc I'C~tiliilW. 
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I~l'CdOlllhialll p;l l i  o f  l~Ol)lnofphOlit i~'ledr c¢th a l ld  fo i  il ~tii,ll lcf l)afi 
~ll' lyl l lpl lo¢yt~'~, r,¢~!dli,ll ¢l-ylhl 'o¢)l¢~ ;liid pl; it¢l¢l l  ( ..; 2(lt'~1, 
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(ll, I i l tM i~hcl i ) l i t i¢ lhbl~i l l fo l l )q fh ior i i l¢ .  2 pM I¢tl l '~pthl,  I / l l4' l i l l  
I i 'yp~il l  inh ib i tor ,  0,1 l ' l l J  ' l l i l  apro l i l t i i l  :llld holnot l t ' l l i /¢d ~i l l l  tl 
i~olylfOll  n l ixcr  oi l  i~'¢. A f te r  ¢¢nt l'iflll~;iliOll ill l i) l100I}-: g for  I h, i lie 
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l~liril ' icd frOlll the cylosol i¢ fi';~ciioil~ tilili~.; ih~.. ¢ohi l l i l l  
~:hrOlllillOi4ral~hY 'il~.'l~ ,1~ ~ti l l i l lCd hi 1';il~tc I, which is ~imilar id the 
i~roeedUl'~ fl'Olll Ka l io l l  ¢1 al, pfl. except thai  MS""  ~as Oll l i i lcd in al l  
• ~icp~, l, 't irlherii l~lrc, A' I 'P ~;l~ o in i l t cd  dur ing sah 14radicilt ehil iOil i l l  
the  ,4Tl~-ai4aro~e ct~llllUll step. This wl i l  c~¢llt i i t l  It, scparalc l ) t ;  
ki i l l is¢ froi l i  Olher/Vlq~.i l l4: lro~e bi l l t l i l l l l  pl'oi¢ii ls, l l i gh ly  pt ir i f ied I ) t l  
khlas¢ (80 plO w:l~ u~ed for lilltilWi acid ~¢qUellCilll.t, a~, described l i 6}. 
2,,1, DG kittasc #ss~Lv 
Fllzylue I~r¢l~aration'~ (20/tl, tllaxiinally 20 pl-~ prot¢ill) were hi- 
,:rib;lied hi all assay mixture (240,.11 cont;ihlin.u 50 inM "l'ds.llCI (pl i 
7.5), 10 mM NaF, 1(3 llIN1 MgCI.h 0,5 luM dithiotllreitol, 1 inM 
t.liol¢in, 2 nlM PS, 1 inM deoxycholate aud 2 n'iM I)-!:PIATP. 'rhc 
reactioil was started by the addition of i~-'UP]A'I'P arid terminated 
~tfter 3mit~ incubation at 30"C by nlixinll 200pl assay mixture Wilh 3,6 
ml cbloroformfnieth:lnol/2 M NaCI (1:2:0,6, v/v/v). The formation 
of PA was iitiear in tinl¢ for at least 10 mhl, After vortexiilg, 1 nil 
chloroform and 1 ml 2 M NoCI were :tdded, followed again by' vortex- 
ills, The chlorofornl phase w:ls analyzed by thin layer 
chronlatogrul)hY on silica 8el plates (1)C fertit.4platten, Kieselgel 60; 
Merck) with chloroforln/methanol/acetic ilcid/l'l..() (50:30:2:4, 
v/v/v/v) as devdopin8 solvent, PA and LPA spots were detected by 
~autoradio8raphy, scraped off aiid quantitatcd by' liquid scintlllatioi~ 
counting. More than 90% of the S"P-labcl was recovered in the PA 
spot, 
2.4. PCR and cDN/1 cloning 
The PCR mixture contained 10 mM 'rris-HCl, pl-I 8.3° 50 mM KCI, 
1,5 mM MICI~, 0.0010,'0 lt~:latin, 0,25 mM of each dNTP, 1/~8 of each 
primer, and 2,5 units of Taq polymerase (native Taq or re¢0mbin,ant 
AmpliTaq, both from Perkin Elmer Cetus) in a total volume of 50/d 
or lO0,ul. All PCR reactions were carried out with themmcyclins con. 
ditions as specified by Perkin Elmer Cetus, with a S0°C annealing 
temperature, using normally 30 cycles. Two Astl0 human eDNA 
libraries were screened to obtain a full-lensth DG kinase eDNA. A 
Jurkat T-cell eDNA library (Clontech) was screened with a randomly 
primed SiP-labeled PCR DNA-frasment, Plaque purifications were 
carried out usin8 standard procedures [17]. eDNA inserts from 
purified plaques were subsequently dise,~tcd with Ec'oRi and clotted 
Table I 
Purification of DG kinas¢ from cytosol of human WBC and pill brain 
Volume $p¢c. act, Activity Purifi- Protein 
(ml) (nmol/min yield cation (ms) 
per rag) (e/0) factor 
Human white blood cells 
cytosol 600 6.5 10(3 1 2160 
DE 52 290 26.0 68 4 371 
(NH.i)aSO,l 9 I 1.8 24 1,8 286 
GIS0 38 53.4 10 8,2 26 
ATP asarose 22 6913 6 1064 0,13 
hl lo  all I,'¢~,RI .l i~c~h'd iq i i  N l , t / f i , i  ~¢ch,l. :% I)NI; I , t l  I',~'¢!1 
l¢lik~-illic ¢cll ,~I IN,\  l ibf .tr)  {killd[,~ p lo~tded I~) i ' .  i Io~l lstc l lb; leh.  
I t~to lO  ~.~,~ l~,'f¢t-'lll:'tl Vi i ltt  I INA  II<;lt~lll~*lll~ l'tOlll ple~iou~l~, c lo l lcd 
el)N, , \ ,  
'~llfi.l'A(:;l,, o1~ lit% 1.'¢1'. ~,l~ !~¢rfoimed :l¢,;oh.lut,~ to l.a¢luillli 
I lS] ,  I ' ro l¢ i l i  ~;ix delernl i l ied ;ww~,rdiug i~, P¢lCt'~Oll [1'I I, I IN¢\  So. 
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' FAMAI I , '  [21] I, I 'o l l i l  IIN,,% ;Uld po ly l ,A l '  RNA ~crc  I>urified ~' i ih 
s l l l l idard l{~.'hllillti¢~ 1171, I tNA ~:l~ lep;l i ' ; ited on I~'o :lglll'O~¢. for~ 
il lalth;'hyd¢ 14el'i, I rlil~f¢i'l't~d to il,%,loli i iwiIibf.'tl l¢ II i v l~i lnd,~,  ~il i ief- 
sll~till) ai ld h,vbf id i ted ~,i, l l l i  ~:P. labcled i 'ai ldoll l lb ~ i~l'iilted prol,¢~ (tim. 
cc~rtlliig to Al i ler,~hil l i l i .  'l'ol~tl I~,N;%, f f0 i i / I  I~.[dl cel l . ,  A.131 c¢11~, anti  
( i l  ,U.2 cc lh a~ ~c l l  a~ ,>t ht l l l la l l  a,¢lill I)N,,% r~rob¢ ~,~'¢r~, it i-,.¢il~'rotl~ l l i f l  
f ro l i i  M,  ( i cbb i i l k  hi otlr inil i ltl i~.., ('(}.'.;.7 cell II';llt~ft.'¢llOllS ~,~,Cl't' pcr.  
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3, RESULTS AND I)ISCUSSION 
3, I. Purification and churacterization of  DG kimtse 
from huntan normal white blood cells 
The purification of DG kinase was undertaken 
because an initial observation suggested th~ presence of 
DG kinase activity it'l highly purified PKC preluarations 
(R.v.d.B. unpublished results), obtained after affinity 
column chromatochraphy on immobilized PS [22]. 1"o 
investlgate tl~.c po~;sibility whether PKC could itself 
phosphorylatc tlle physiological activator, DG, the 
separation of the two activities was the original aim, 
Upon homogenization of WBC, 90e/o of the DG 
kinase activity was recovered in the cytosol fraction, 
whick displayed a 2-fold higher specific activity than 
the microsomal fraction. As shown in Table I, purifica- 
tion resulted in preparations that were 1000-fold in- 
creased in specific activity compared with cytosol. 
Upon (NH4)zSO.~ precipitation, no increase in specific 
activity was observed. However, omittanee of this step 
resulted in less pure preparations as judged on SDS- 
PAGE (data not shown). In the final step of the 
purification, DG kinase activity eluted from an ATP 
agarose column at about 400 mM NaCl (Fig. 1) and co- 
purified with a band of appro×imately 86 kDa as 
detected on silver stained SDS-polyaerylamide gels (Fig. 
1). These fractions were devoid of PKC activity 
(measured as descibed in [22]). In a similar rnanner, DG 
kinase was also purified from pig brain cytosol (results 
not shown). In this case, final preparations also 
displayed an 86 kDa band on SDS-PAGE (Fig. 1). After 
ATP agarose chromatography the enzyme was very 
unstable, 90°70 being lost within a f<;w hours at 0°C. 
Stability could not be improved by addition of known 
stabilizing agents, such as: bovine serum albumin, ATP 
[9] or PS liposomes [23]. Upon gel filtration of human 
WBC cytosol, DG kinase activity eluted at a molecular 
mass of approximately 87 kDa (results not shown). This 
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Fig. 1. SDS polyacrxlamide g l analysis (silver stain) of ATP agarose column fractions of human WBC DG kinase. 50/~1 of each column fraction 
was Io,aded per slot. The Upl~er part of tl~e figure shows the DG kinase activity told the NaCI concentration (measured by conductivity) in each 
fraction, fl, buffer only; P, purified DG kinase from pig brain cytosol (similarly purified as human WBC I)G kinase); S, starting material loaded 
on tile ATP agarose cohtnm. 
indicates that the native enzyme of human WBC con- 
sists of a single polypeptide. 
It is likely that myeloid cells are the main source of 
our purified WBC enzyme as WBC preparations con- 
sisted for the predominant part of polymorphonuclear 
(myeloid) ceils. This argues against he suggestion [24] 
that, among the different types of peripheral blood 
cells, the presence of DG kinase (the structure of which 
we report) would be restricted to lymphocytes. In addi- 
tion, the 86 kDa DG kinase could also be isolated from 
blast cells from a patient suffering from acute myeloid 
leukemia (results not shown). 
The WBC DG kinase shows optimal activity in the 
presence of PS and deoxycholate (DOC) as cofactors 
and lower activity in the presence of PC (results not 
shown). The observation that DG kinase itself is 
stimulated by PS, and therefore presumably possesses 
binding site(s) for this phospholipid could explain the 
observed retention of DG kinase activity on immobiliz- 
ed PS during purification of PKC (see above). In the 
presence of 2 mM PS and 1 mM DOC, a K.~ for 1,2-sn. 
diolein of 0.45 mM was measured, similar to the 1 mM 
value reported for a bovine brain DG kinase [25], but 
significantly higher than reported for a 80 kDa pig brain 
enzyme (60/~M) [9]. The K,, for ATP with and without 
1 mM DOC is 1.6 mM and 0.5 mM respectively, similar 
to other values of DG kinase preparations, that were 
determined only in the presence of DOC [9,25]. 
DG analogs containing an unsaturated fatty acid at 
the ~n-2 position gave optimal enzyme activity (Table 
II), irrespective of the presence of DOC (results not 
shown). The low but detectable activity observed with 
1,3-sn.diolein can be explained by a 5-10% contamina- 
tion of the substrate with the !,?-~en isomer, as 
measured by HPLC. Of the monoacylglycerols tested, 
only 2-monooleoyl-rac-glycerol was phosphorylated by 
our DG kinase preparation, although with: low efficien- 
cy (Table II). Since DG kindle is an enzyme of the PI- 
cycle, its natural substrate could be 1-stearoyl-2- 
arachidonoyl-sn-glycerol, thought o be the main DG 
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dupl i , : : | te' ,  d i f fered by less thiuI 15t~'0 
analog generated from l~hosplloiriosit~des [26,27]. In- 
deed, for membra,~,'-bound I)G kinasc in Swiss 3T3 
fibroblasts ~tnd baboon brain, this particular DG 
analog has been shown to be a preferred substrate, 
rather than 2-oleoyl DG analogs [10,13]. However, in 
the cytosol of Swiss 3"I'3 cells DG kinase activity did not 
display this DG pret'crence [10], su~,gesting the existence 
of different types of DG kinases. In WBC, we did not 
find such a particular DG preference for either mem- 
brane,bound DG kinasc (results not shown), or for the 
purified cytosolic enzyme (Table II), also in the absence 
of DOC (not shown). With these preparations, imilar 
activities are measured with DG substrates expected to 
be formed from PI- as well as PC-breakdown [28]. As 
receptor-mediated PC breakdown isnow accepted to be 
a ubiquitous phenomenon (for review see [29]), the 
broad DG specificity of human DG kinase could also 
imply a role for the enzyme in this pathway. Analogs 
containing an ether.linked residue at the sit.1 position 
(1-O-hexadecyl-2-oleoyl-rac-glycerol) were also 
substrates for human DG kinase, but those containing 
2 ether-linked residues (l,2-O-dioctadecyl-sn-glycerol 
and 1-O.hexadecyl-2-O.methyl.rac-glycerol) were not 
(Table II); these compounds likewise can be generated 
by agonist-induced hydrolysis of ether-linked PC [30]. 
Among the compounds which have been described to 
inhibit DG kinase [31,32], the compound R59022 [32] is 
indeed a potent inhibitor of the human WBC enzyme, 
but 1-monooleoylglycerol and 1,2-dioctanoylethylene 
glycol are not (data not shown). Furthermore, the en- 
zyme is also inhibited by .,v'-ethylmaleimide and 
N,N'-O-phenylenedimaleimide (data not shown). This 
finding, together with the observation that the enzyme 
is stabilized by dithiothreitol, suggests that one or more 
free sulfbydryl groups in the enzyme play an essential 
role in its catalytic action. 
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3.2. PC?R cD/V/I cloning attd sequettcttt.~, o.f hu,tavt I)G 
h'ittasc, 
Starting from abottt It)00 buffy coats (which is the 
equivalent of approximately 40f) liters of blood), 80 ,ttg 
of DG kilaase was obtained iu highly :~urified form. 
Following electroblotting of the enzyme, tryptic pep- 
tides were prepared, and after purificatioll by I-IPI..C, 
two of them were seqttenccd: peptide A, 
EIDYDGSGSVSQAEXVR (no definitive assigtmlent 
but a likely Trp at position 15), and peptide B, 
w/vci/lt~i/ic~/r, aYEGQN LAK (two residues were 
detected in each of the first four cycles during gas phrase 
sequencing). The degenerate oligonucleotide sequence 
of peptide A was divided in three regions, and the 
highly degenerate middle 16 nu¢leotides were amplified 
with PCR using degenerate primers based on the se- 
quence from the extremities of peptide A. First strand 
eDNA from Jurkat cells was used as a template. The ex- 
pected 51 bp fragment was amplified, extracted from 
gel, used for PCR reamplification, and then cloned. 
The unique sequence of the 16 bp middle region could 
thus be determined for peptide A and indeed fully mat- 
ched the amino acid sequence. The 16 nucleotide se- 
quence together with 6 bases at the 5' end and 5 bases 
at the 3' end yielded a 29 bp primer that was only 8-fold 
degenerate. This sequence, forward and reverse, was 
synthesized with a 5' adaptor' GATCGAATTC, and us- 
ed in combination with B primers (deduced from pep- 
tide B) on Jurkat cell first strand eDNA. The combina- 
tion of the 8-fold degenerate A forward primer with a 
reverse 4096-fold degenerate B primer yielded a single 
0.95 kb DNA fragment. 
The 0.95 kb fragment was labeled by random priming 
and used as a probe to screen  10 6 plaques from a Jurkat 
cell hgtlO eDNA library. The majority of the strongly 
hybridising plaques contained a 2.1 kb insert. Two 
Voh i l t l c  .7~,, I l l l l l l hc l  ~ I ~. I I  I t " .  1,1' I ' [ I  I t~  No~ c t l lbc r  19~1i} 
~:hnic~ with ilr, Ci'l~ o f  2. I kb alld I ,t) kh ~ ci'c" -aihchtll~'d 
~llid ti~ctl fol > 'icqll¢li¢¢ ;ul;lly~i',, I lo ih s~='¢lll¢llc'('~ dcd,, : ,  
cd fl'Oili p¢l~litl¢~ A ~illtl B. wci'e l)l'¢,i¢ilt ~viihiu Ihc 
hii'~ci' hi~crl. Siilcc bolh ¢1o11¢ ~, +Hiu'l ;il cxi i¢l ly lh¢ ~llillc 
po~itiO,i, bec;itl~¢ v;il'ioti~ 2. l kb clolle~ tNci'¢ isolated, 
~tlttl al~o J)¢qi|llS¢ fJlq h311g¢~t (J]scll rcadh}g fril l l l¢ did llOt 
liav¢ 5' up,~li'caln it1 fi'alllC ',lOp ¢odon,,, ~v¢ sii,,l~¢c'lctl 
Il iat out' hi i l l la i l  i ) ( i  killa~C ¢IV)NP% h;id tilt hl lcr i la l  
lVcoRl ~it¢ at the 5' ;¢iid of  both miOliCS. Shi¢¢ llo atltli- 
t ioi lal  i'i'ligin¢lll~ had b~¢ll dcte¢led al'lcr/-;'coRl dil-~¢s,. 
l ion of the I~hlil4¢ I )NA~ froi l l  Jurkal A{ll l f l  ¢1oi1¢.% ii l-  
,~¢i'l'i l~¢d to ¢oiis(i'li¢l the gt 11) l ibrary probably had not 
i~ceil i)ropci'ly nl¢illyhitcd. A xeCOlid )gi l t )¢I)NA 
l ibrary (froi i l  l lUll lali DNI)41 Ictikemic T-cells) wa,s 
.screcllcd with ~,~. i.0 kb 5' cDNA frzq~mcnt, hlscrt.s from 
20 i:ioh~tcd clollcs wcrc directly atnl'fliFicd by P('R wifll 
either Ab, tlO primer (5' or 3' cml) in combimliion with 
all i i iteriial l ) ( i  kiliasc pl' i l l lCr ill i'¢Vel'Sl~ i l l ld coinpl¢- 
in¢l ltary or icni i t l ion.  Two l~(~lt pl'odlicts frol i l  illdCp¢il- 
d~lit pllagc clones w¢1'¢ t'urlher ailalysed, l ]olh PCIt  
fruglnenls were 0.9 kb Ioll l l  and hi(Iced ¢ontuil led an i l i -  
tt21'n0.1 EcoP, l site. "rhe fl'agillcllt.~ were tligcstc¢l with 
/Scol~,I, clolied and ,~equenced. Botla clones were ideil- 
;iczil in sequence. Direct scqucncintl of" the two oritlinal 
PC'R-l'ragnleiits derived froni phage DNA (not EcoR[ 
digested) using primer AGAGCCACTGCCATCNI"  
(position 609) confirmed that these clones contained the 
sequence adjacent o the internal EcoRl site (position 
449). A 5' clone was ligated at the EcoRl site with a 2.1 
kb clone to obtain a full-length hummi DG kinasc 
cl)NA. 
3.3. Human DG L'inase eDNA ctnd amino ucid 
sequence comparison with other protei#ls 
The eDNA sequence of human DG kinase contai,-:~ a 
single open reading frame of 2205 bp encoding a protein 
of 735 amino acids. The leader sequence contains one in 
frame stop codon followed downstream by an in 
frame start codon. Although this start codon 
(GACAGATGG) does not have the conserved features 
of a Kozak sequence (CCACCATGG) [33] it is the only 
apparent start for translation. The 3' untranslated 
region contains the canonical polyadenylation signal 
AATAAA. 
The deduced amino acid sequence of 735 residues 
corresponds with a calculated Mr of 82 671 Da, which 
is close to the 86 kDa actually observed for tbe parified 
DG.kinase on SDS-PAGE. The sequence of both pep- 
tide A and B were found in the human DG kinase se- 
quence at position 166 and 473, respectively (Fig. 2). In 
retrospect i is clear that peptide B was contaminated 
with another tryptic peptide of DG kinase, FHIM, 
which was identified at amino acid position 537, and ex- 
plains the double amino acid sequence obtained at the 
first four cycle.~ of degradation. As expected, peptide A
and B were both preceded by a basic amino acid, 
necessary for tryptic cleavage. 
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sites (asterisks) are indicated. 
Analysis of the primary structure o f  human DG 
kinase reveals the presence of two EF-hand structure.~ at
amino acid positions 123 and 168, both contain the con- 
served sequence ZxZxZxxxZxxZ, where Z is Ser, Thr, 
Glx or Asx (for review see [34]). The presence of a dou- 
ble EF-hand structure indicates a functional Ca 2+ bin- 
ding site for DG kinase. Sequence similarity in the EF- 
hands extends beyond only the Z-residues, when com- 
pared with for instance calmodulin or troponin C (Fig. 
3). Rather unexpectedly, we could not detect any Ca 2÷ 
dependence of either the purified enzyme, or of the ex- 
pressed enzyme in DG kinase transfected COS-7 ceils 
(see below); activities of the enzyme did not vary by 
more than 10°70 in the presence of 10 mM EGTA (in- 
eluding a 1 hour prcincubation with EGTA at 4°C) 
when compared with varying concentrations of Ca 2÷ in 
the assay (irrespective of the presence of DOe). At pre, 
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oll t lw I ' ; l l  I l'i!J, hl, 
sent wc do aot know if I)G kinase fails to bind Ca""; 
conceivably our assay renders tile enzyme Ca"" in- 
dependent, or Ca ~'''' is not required for activity of DG 
kinase but rather fulfills another as yet unidentified 
function. An interesting feature is the presence of  tWO 
cysteine repeats starting at Positions 219 and 282. 
Similar double cysteine repeats are also present in the 
C-I region of all PKC isotypes and in several 
metalloproteins (for review see [37]). For DG kiaasc 
and PKC, this homology is not restricted to the cysteine 
residues within each cysteine repeat, but extends to ad- 
ditional amino acids within these structures. Using dele- 
tion mutants and site-directed mutagenesis, tile double 
cysteine repeat of PKC has been identified as the phor- 
bol ester binding site [381. Because phorbol esters and 
DG compete for binding to PKC [39], the double cys. 
teine repeat of DG kinase could likewise be its DG bin- 
ding site. 
Finally, DG kinase contains two putative ATP bin. 
ding sites (Fig. 2) one of which resides within the first 
cysteine repeat of DG kinase. At present it is unknown 
whether both constitute active ATP binding sites. 
We specifically compared the sequence of human DG 
kinase with those of other DG metabolizing enzymc~, 
such as E. coli DG kinase and sml,2-diacylglycerol 
cholinephosphotransferase (CPT- I) [40,41 ]. These pro- 
teins did not show any significant similarity with human 
DG kinase, suggesting that the DG binding site has not 
been conserved in the course of evolution. A 
phospholipid binding protein, that shares homology 
with PKC in a putative PS binding domain, referred to 
as p65, did not show any homology with DG kinase 
[42], even though DG kinase displays optimal activities 
in the presence of PS (results not shown). 
While the sequence of our human DG kinase eDNA 
was being completed, a DG-kinase sequence from pig 
was published [1]. The pig enzyme is homologous to the 
human DG kinase with 51 amino acid differences and 
one amino acid insertion at position 88 for human DG 
kinas¢. Striking is the long stretch of 110 amino acids 
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following tile seColld ATP binding sile, thai is fully con., 
served betweel l  hunmn ami pig DG kinasc (i':it.~. 2). 
3,4, RNA blotting attaty.s'is 
Northern blot ~malysis showed a single mRNA 
species ot' 3,2 kb (Fig, 4), Exprcssknl of DG kinase 
mRNA was high in normal httm:tn T-cells and Jurkat 
1 2 "3 4 5 
'I 
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Fig, 4, Northern blot analysis of DG kinase mRNA. Total RNA. (20 
/~g/lane) from Jurkat cells, normal human T-cells, A431 cells, HeLa 
cells, and GLC2 calls (lanes 1, 2, 3, 4 and 5, respectively) were 
separated on a 1070 agarose formaldehyde gel and transferred to a 
nylon membrane. The filter was hybridized with a 1.0 kb DNA frag- 
ment (starting at the internal EcoRI site) and exposed for 4 h. DG 
kinase mRNA is detectable as a single 3.2 kb mRNA. The bottom 
panel shows an overexposure (3 days) of the 3.2 kb DG kinase region 
of the blot. This exposure reveals DG kinase mRNA in I-leLa cells, 
and a faint band for A431 ceils and GLC2 ceils. Equal quantities of 
RNA had been loaded, as judged from hybridisution with a human 
actin eDNA probe (data not shown), 
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cells (htmtzui leukemic T-cells) This is in agreement 
with in'lmttliological quantitation studies of I3G kinase 
[24]. 13G kitiasc InR.NA v,,a,,i expressed at .'t low level ill 
lqcLa cells (hurrian cervix carcinoma), and barely detec- 
table in A431 cells (humal] epidcrmoid carcinoma) and 
GI.C2 cells (srriall cellular lung carcinoma), 
3.5, F-'xpression of  DG Rinase in COS.7 cell.~ 
The full.length DG kinasc eDNA was subcloncd into 
the e.'.:pressio|l vector pMT-2, and transfccted into 
COS.7 cells. After 2 days cells were harvested, lysed and 
assayed for DG kinase activity. As shown in Fig. 5, cells 
transfected with human DG kinase contained 6-7-fold 
higher activity compared with control cells. Absolute 
values of activities for total cell lysates were 35-38 nmol 
PA/min/mg for DG kinase transfected cells. This 
overexpression yields lligh DG kinase activities, when 
compared with non-transfected COS-7 cells (4-5 
nmol/min/mg), pig brain cytosol (2-3 nmol/irlin/mg), 
or WBC cytosol (6-7 nmol/min/mg). These ex- 
periments are the first to clearly demonstrate high DG 
kinase activity ia a eukaryotic system, associated with 
the expression of DG kinase eDNA. 
3,6. Concluding remart~s 
The cloning and expression of the human DG kinase 
eDNA allows us to study enzymatic and regulatory pro- 
perties of this enzyme, and to determine its role in signal 
transduction. Not only as a possible regulator of PKC, 
but also as an enzyme that generates PA, which may 
function as a second messenger in its own right. 
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